Biguanides

Caroline Day; Clifford J. Bailey

doi:10.1016/B978-008055232-3.61041-4

Biguanides

Caroline Day^*
, Clifford J. Bailey

^*Corresponding author for this work

Aston University

Research output: Chapter in Book/Published conference output › Chapter (peer-reviewed) › peer-review

1 Citation (Scopus)

Abstract

The biguanides are derivatives of the compound biguanide (guanylguanidine) that exert a blood glucose-lowering effect in type 2 (non-insulin dependent) diabetes mellitus. The main biguanides are metformin (dimethylbiguanide) and phenformin (phenethylbiguanide), which were described in 1957 and buformin (butylbiguaninde), which was described in 1958 ....

Original language	English
Title of host publication	xPharm
Subtitle of host publication	the comprehensive pharmacology reference
Editors	S.J. Enna, David B. Bylund
Publisher	Elsevier
Number of pages	3
ISBN (Print)	978-0-08-055232-3
DOIs	https://doi.org/10.1016/B978-008055232-3.61041-4
Publication status	Published - Feb 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/B978-008055232-3.61041-4

Cite this

@inbook{6e33844742164f2b82b1a7ecdc28e8fe,

title = "Biguanides",

abstract = "The biguanides are derivatives of the compound biguanide (guanylguanidine) that exert a blood glucose-lowering effect in type 2 (non-insulin dependent) diabetes mellitus. The main biguanides are metformin (dimethylbiguanide) and phenformin (phenethylbiguanide), which were described in 1957 and buformin (butylbiguaninde), which was described in 1958 ....",

author = "Caroline Day and Bailey, \{Clifford J.\}",

year = "2011",

month = feb,

doi = "10.1016/B978-008055232-3.61041-4",

language = "English",

isbn = "978-0-08-055232-3",

editor = "S.J. Enna and Bylund, \{David B.\}",

booktitle = "xPharm",

publisher = "Elsevier",

address = "Netherlands",

}

TY - CHAP

T1 - Biguanides

AU - Day, Caroline

AU - Bailey, Clifford J.

PY - 2011/2

Y1 - 2011/2

N2 - The biguanides are derivatives of the compound biguanide (guanylguanidine) that exert a blood glucose-lowering effect in type 2 (non-insulin dependent) diabetes mellitus. The main biguanides are metformin (dimethylbiguanide) and phenformin (phenethylbiguanide), which were described in 1957 and buformin (butylbiguaninde), which was described in 1958 ....

AB - The biguanides are derivatives of the compound biguanide (guanylguanidine) that exert a blood glucose-lowering effect in type 2 (non-insulin dependent) diabetes mellitus. The main biguanides are metformin (dimethylbiguanide) and phenformin (phenethylbiguanide), which were described in 1957 and buformin (butylbiguaninde), which was described in 1958 ....

UR - https://www.scopus.com/pages/publications/84883923426

U2 - 10.1016/B978-008055232-3.61041-4

DO - 10.1016/B978-008055232-3.61041-4

M3 - Chapter (peer-reviewed)

SN - 978-0-08-055232-3

BT - xPharm

A2 - Enna, S.J.

A2 - Bylund, David B.

PB - Elsevier

ER -

Biguanides

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Ciglitazone

Metformin

Pioglitazone

Cite this